January 22, 2009 Mr. Leo Pavliv 707 Walcott Way Cary, NC 27519 Re: Employment of Leo Pavliv as Vice President, Operations by Cumberland Pharmaceuticals Inc. Dear Leo:Employment Agreement • February 18th, 2009 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledFebruary 18th, 2009 Company IndustryEffective January 1st, 2009, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”). In consideration of your appointment as Vice President, Operations of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. THIRD AMENDED AND RESTATED LOAN AGREEMENT December 30, 2008 by and between CUMBERLAND PHARMACEUTICALS,...Loan Agreement • February 18th, 2009 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
Contract Type FiledFebruary 18th, 2009 Company Industry JurisdictionTHIS THIRD AMENDED AND RESTATED LOAN AGREEMENT (the “Agreement”) dated as of December 30, 2008, is between BANK OF AMERICA, N.A., a national banking association (the “Bank”) and CUMBERLAND PHARMACEUTICALS, INC., a Tennessee corporation (the “Borrower”).
January 22, 2009 Mr. David L. Lowrance 422 William Wallace Drive Franklin, TN 37064 Re: Employment of David L. Lowrance as Vice President and Chief Financial Officer by Cumberland Pharmaceuticals Inc. Dear Dave:Employment Agreement • February 18th, 2009 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledFebruary 18th, 2009 Company IndustryEffective January 1st, 2009, this letter agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”). In consideration of your appointment as Vice President and Chief Financial Officer of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows: